首页 | 本学科首页   官方微博 | 高级检索  
     

厄贝沙坦联合氢氯噻嗪治疗原发性高血压病的临床观察
引用本文:张世恒,李庆光. 厄贝沙坦联合氢氯噻嗪治疗原发性高血压病的临床观察[J]. 中国实用医药, 2010, 5(15): 61-62
作者姓名:张世恒  李庆光
作者单位:1. 河南省南阳市第八人民医院,473000
2. 南阳理工学院医务室
摘    要:目的观察厄贝沙坦与氢氯噻嗪联合治疗原发性高血压病的临床疗效。方法 120例原发性高血压病患者,随机分为治疗组60例,给予厄贝沙坦联合氢氯噻嗪治疗;对照组60例,单用厄贝沙坦治疗。疗程均为12周。结果总有效率治疗组91.7%,对照组76.7%,两组比较差异有统计学意义(P〈0.05)。结论厄贝沙坦联合氢氯噻嗪治疗原发性高血压,疗效优于单用厄贝沙坦。

关 键 词:原发性高血压  厄贝沙坦  氢氯噻嗪

Clinical study on treatment of essential hypertension by Irastan and Hydrochlorothiazide
Affiliation:ZHANG Shing-heng.(Nangyang Eighth People’s Hospital,Henan,Nangyang 473000 , China )
Abstract:Objective To investigate the effects of treatment of hypertension with Irbesartan and Hydrochlorothiazide.Methods 120 patients were randomly divided into treatment group treated by Irastan and Hydrochlorothiazide and control group treated by Irastan.Results The effective rates in treatment group was 91.7% and the other was 76.7%. The difference between these two groups was statistically significant (P<0.05).Conclusion The clinical efficacy of Irbesartan and Hydrochlorothiazide is better than that of Irbesar...
Keywords:Hypertension  Irbesartan  Hydrochlorothiazide  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号